Nkarta Appoints Shawn Rose Chief Medical Officer & Head of R&D
06 Jun 2025 //
GLOBENEWSWIRE
Tevogen Bio names David E. Banko Global Head of Government Affair
25 Mar 2025 //
GLOBENEWSWIRE
FluidForm CTO Adam Feinberg To Join 2025 SXSW Conference
04 Mar 2025 //
GLOBENEWSWIRE
CTMC & Syenex Launch Partnership to Scalability of Cell Therapies
08 Jan 2025 //
BUSINESSWIRE
FluidForm Bio To Join Biotech Showcase And LifeSci Partners Event
08 Jan 2025 //
GLOBENEWSWIRE
Tessera Therapeutics Presents Sickle Cell & T-Cell Data at ASH
05 Nov 2024 //
GLOBENEWSWIRE
Lyell Presents Phase 1-2 Data for IMPT-314 in B-cell Lymphoma
05 Nov 2024 //
GLOBENEWSWIRE
Tevogen Bio Highlights the Publication of Promising Trial Data
15 Oct 2024 //
GLOBENEWSWIRE
NMDP BioTherapies Relaunches Services For Autologous Cell Therapies
07 Oct 2024 //
BUSINESSWIRE
NMDP Raises $1.1M At Gala For Cell Therapy Access
03 Oct 2024 //
GLOBENEWSWIRE
MaxCyte Signs Platform License With Kamau For Cell Therapy Development
16 Sep 2024 //
GLOBENEWSWIRE
Acepodia and Pfizer Collaborate to Advance Chemistry-Based Cell Therapies
03 Sep 2024 //
FIERCE BIOTECH
Pan Cancer T Raises €4.25M For Next-Gen T Cell Therapies
11 Jul 2024 //
GLOBENEWSWIRE
Cell therapy reckoning: How to get cell therapies flying off-the-shelf
31 May 2024 //
FIERCE BIOTECH
Astellas, Poseida Collaborate On Allogeneic Cell Therapies In Oncology
01 May 2024 //
PR NEWSWIRE
Cellares Unveils Cell Q, Automated QC Workcell For Cell Therapies
18 Apr 2024 //
BUSINESSWIRE
T-knife bags $110M for raft of cell therapy solid tumor trials
02 Aug 2021 //
FIERCEBIOTECH
Gene editing biotech Caribou Biosciences sets terms for $203 million IPO
19 Jul 2021 //
NASDAQ
Fierce 15 winner Senti is picking up a factory all its own
25 Jun 2021 //
FIERCEPHARMA
CellPoint and Lonza Enter Strategic Collaboration
24 Jun 2021 //
CONTRACTPHARMA
ProCell to Develop Automated Production Unit for CAR-T Cell Therapies
09 Jun 2021 //
CONTRACTPHARMA
The primary failed. The key secondary failed. But this biotech still believes
17 Nov 2020 //
ENDPTS